Dr.Hilmi Apak (Hematologist/oncologist, Pediatric hematologist, Pediatric hematologist/oncologist)– Best Costs, Reviews – Book Your Consultation

Professional Experience

• Current: Pediatric Hematology‑Oncology Specialist, Biruni University Hospital, Istanbul (since 2023)
• Head of Division: Pediatric Hematology‑Oncology, Istanbul University‑Cerrahpaşa (2002–2024)
• Head of Pediatrics Department: Istanbul University (since 2007)
• Consultant: Pediatric Hematology‑Oncology at Liv Hospital (2013–2021)
• Academic Board Member: Department of Pediatrics, Istanbul University (since 2002)

Academic Contributions

• Served as assistant editor for Turkish Pediatrics Archives journal
• Published over 75 international peer‑reviewed articles in hematology and oncology
• Presented original data on chronic pediatric ITP and Hodgkin lymphoma at national and international meetings
• Mentored numerous residents and fellows in pediatric hematology‑oncology

Areas of Expertise

Prof. Dr. Apak treats a broad range of pediatric blood and cancer conditions:

• Leukemia: Diagnosis and chemotherapy protocols for acute leukemias
• Lymphomas: Treatment of Hodgkin and non‑Hodgkin lymphomas, including immunotherapy
• Bone Marrow Transplant: Performing autologous, allogeneic, haploidentical stem cell transplants
• Chronic ITP: Managing low platelet counts with medical therapy and with splenectomy where necessary
• Rare Disorders: Treating mastocytosis, hemoglobinopathies, Glanzmann thrombasthenia and related conditions
• CAR‑T Therapy: Advanced cellular therapy for relapsed blood cancers

Publications and Research

Prof. Dr. Apak has contributed landmark studies to pediatric hematology-oncology:

• Experience with pediatric chronic immune thrombocytopenia over 30 years: confirmed that one-third of cases remit spontaneously, with splenectomy effective for severe cases.
• Study on EBV LMP‑1 staining in childhood Hodgkin lymphoma: assessed prognostic value of viral markers in survival outcomes.
• Retrospective review of febrile neutropenia in children with ALL: supported improvements in supportive care protocols.

Patient Care Philosophy

• Emphasizes compassionate, family‑centered communication, providing clear explanations to parents
• Supports informed decision‑making through education on treatments and side effects
• Welcomes international patients with structured online consultations and cultural sensitivity
• Strives for optimal clinical outcomes with minimal stress for children and families

Professional Affiliations

• Professor and former Head of Pediatric Hematology‑Oncology at Istanbul University‑Cerrahpaşa
• Member of Turkish Pediatric Oncology Society, Turkish Pediatric Hematology Society, Turkish Pediatric Association
• Served as assistant editor of Turkish Pediatrics Archives journal
• Licensed pediatric hematologist‑oncologist in Turkey

FAQs

Is Dr. Hilmi Apak board‑certified?

Yes, he is board‑certified in pediatrics and pediatric hematology‑oncology, with over 25 years of practice.

What treatments does he perform?

He provides leukemia and lymphoma chemotherapy, bone marrow transplants, CAR‑T therapy, and treats benign blood disorders like ITP and thalassemia.

Does he treat international patients?

Yes, he manages international referrals with online pre‑consultations and coordination of treatment plans.

How long is the typical hospital stay?

Hospital stays vary: chemotherapy may require a few days, while bone marrow transplant care often spans several weeks.

What languages does he speak?

He speaks Turkish fluently and communicates effectively in English.

Does he publish research?

Yes, he has authored over 75 international publications and remains active in clinical research.

Where does he practice?

He practices at Biruni University Hospital in Istanbul and is affiliated with Istanbul University‑Cerrahpaşa.